Showing results (1601-1610 of 1,718) with videos related to
Sort By:
Pageof 172
Skeletal Radiology|December 17, 2013
Case-control study to estimate the performance of dual-energy computed tomography for anterior cruciate ligament tears in patients with history of knee traumaKatrina N Glazebrook, Lee J Brewerton, Shuai Leng, et al.Journal of Healthcare Leadership|July 7, 2023
Bridging the "Know-Do" Gaps in Five Non-Communicable Diseases Using a Common Framework Driven by Implementation ScienceJames F Donohue, J Stuart Elborn, Peter Lansberg, et al.American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|May 13, 2025
Preventing Postoperative Sepsis: Multidisciplinary Implementation of Diverse Countermeasures in our first NSQIP ProjectJ Stuart Wolf, Margaret L Whitney, Rebekah M Summey, et al.ERJ Open Research|December 10, 2024
Automated method of bronchus and artery dimension measurement in an adult bronchiectasis populationAngelina L P Pieters, Qianting Lv, Jennifer J Meerburg, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 8, 2016
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patientsPatrick A Flume, Donald R VanDevanter, Elizabeth E Morgan, et al.World Journal of Urology|May 13, 2014
Impact of warm versus cold ischemia on renal function following partial nephrectomyScott E Eggener, Melanie A Clark, Sergey Shikanov, et al.Hypertension (Dallas, Tex. : 1979)|March 20, 2026
Lifetime Adverse Pregnancy Outcome History and Cardiovascular RiskTiange Liu, Hanne Dahl Vonen, Ricardo Henao, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 17, 2015
A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patientsJ Stuart Elborn, David E Geller, Douglas Conrad, et al.Journal of Clinical Microbiology|June 8, 2018
"Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic FibrosisPeter H Gilligan, Damian G Downey, J Stuart Elborn, et al.Gynecologic Oncology|July 26, 2020
Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort studyBritt K Erickson, Omar Najjar, Shari Damast, et al.Pageof 172